Serine/threonine-specific protein phosphatases and cancer

Expert Opinion on Therapeutic Targets

Volumn 4, Issue 5, 2000, Pages 581-608

  Berndt, Norbert ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

apoptosis; cancer; Cdk; cell cycle; cell survival; checkpoint control; cyclin; drug target; oncogene; protein kinase; protein phosphatase; protein phosphorylation; tumour suppressor

Indexed keywords

EID: 0000983084     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.4.5.581     Document Type: Review

References (221)

1. BARTEK J, LUKAS J, BARTKOVA J: Defects in cell cycle control and cancer. J. Pathol. (1999) 187:95-99.
2. FÅHRAEUS R, FISCHER P, KRAUSZ E, LANE DP: New approaches to cancer therapies. J. Pathol. (1999) 187:138-146.
3. MEIJER L, LECLERC S, LEOST M: Properties and potential applications of chemical inhibitors of cyclin-dependentkinases.Pharmacol. Ther. (1999) 82:279-284.
4. SAUSVILLE EA, ZAHAREVITZ D, GUSSIO R et al.: Cyclin-dependent kinases: initial approaches to exploit a novel therapeutic target. Pharmacol. Ther. (1999) 82:285-292.
5. SHAPIRO GI, HARPER JW: Anticancer drug targets: cell cycle and checkpoint control. J. Clin. Invest. (1999) 104:1645-1653.
6. SELLERS WR, FISHER DE: Apoptosis and cancer drug targeting. J. Clin. Invest. (1999) 104:1655-1661.
7. GIBSON NW, KENNEDY SP: Delivery of tumor suppressor genestoreverse the malignant phenotype. Adv. Drug Deliv. Rev. (1997) 26:119-133.
8. FOLKMAN J: Antiangiogenic gene therapy. Proc. Natl. Acad. Sci. USA (1998) 95:9064-9066.
9. KREBS EG, FISCHER EH: The phosphorylase b to a converting enzyme of rabbit skeletal muscle. Biochim. Biophys. Acta (1956) 20:150-157.
10. FISCHER EH, GRAVES DJ, SNYDER CRITTENDEN ER, KREBS EG: Structure of the site phosphorylated in the phosphorylase b to a reaction. J. Biol. Chem. (1959) 234:1698-1704.
11. HUNTER T: Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling. Cell (1995) 80:225-236.
12. HUNTER T: Phosphotyrosine-a new protein modification. TrendsBiochem. Sci. (1982) 7:246-249.
13. CANTLEY LC, NEEL BG: New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA (1999) 96:4240-4245.
14. HLOBILKOVA A, GULDBERG P, THULLBERG M, ZEUTHEN J, LUKAS J, BARTEK J: Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity. Exp. Cell Res. (2000) 256:571-577.
15. MURRAY AW, HUNT T: The cell cycle-an introduction. WH Freeman & Co., New York, NY, USA (1993).
16. O'FARRELL PH, SU TT: Size control: cell proliferation does not equal growth. Curr. Biol. (1998) 8:R687-R689.
17. CONLON I, RAFF MC: Size control in animal development. Cell (1999) 96:235-244.
18. VAUX DL, KORSMEYER SJ: Cell death in development. Cell (1999) 96:245-254.
19. DAY SJ, LAWRENCE PA: Measuring dimensions: the regulation of size and shape. Development (2000) 127:2977-2987.
20. PARDEE AB: G1 events and regulation of cell proliferation. Science (1989) 246:603-608.
21. ZETTERBERG A, LARSSON O, WIMAN KG: What is the restriction point? Curr. Opin. CellBiol. (1995) 7:835-842.
22. PLANAS-SILVA MD, WEINBERG RA: The restriction point and control of cell proliferation. Curr. Opin. Cell Biol. (1997) 9:768-772.
23. HARTWELL LH, KASTAN MB: Cell cycle control and cancer. Science (1994) 266:1821-1828.
24. PARDEE AB: Growth dysregulation in cancer cells. Adv. Cancer Res. (1994) 65:213-228.
25. SHERR CJ: Cancer cell cycles. Science (1996) 274:1672-1677.
26. PAULOVICH AG, TOCZYSKI DP, HARTWELL LH: When checkpoints fail. Cell (1997) 88:315-321.
27. COLLINS K, JACKS T, PAVLETICH NP: The cell cycle and cancer. Proc. Natl. Acad. Sci. USA (1997) 94:2776-2778.
28. ADAMS PD, KAELIN JR. WG: Negative control elements of the cell cycle in human tumors. Curr. Opin. Cell Biol. (1998) 10:791-797.
29. NIGG EA: Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. BioEssays (1995) 17:471-480.
30. MORGAN DO: Cyclin-dependent kinases: engines, clocks and microprocessors. Ann. Rev. Cell Dev. Biol. (1997) 13:261-291.
31. CHIN L, POMERANTZ J, DEPINHO RA: The INK4a/ARF tumor suppressor: one gene-two products-two pathways. TrendsBiochem. Sci. (1998) 23:291-296.
32. HENGST L, REED SI: Inhibitors of the Cip/Kip family. In: Cyclin Dependent Kinase (CDK) Inhibitors (Vol 227). Vogt PK, Reed SI (Eds.), Springer Verlag, Berlin, Germany (1998):25-41.
33. MURRAY AW: Cyclin ubiquitination: the destructive end of mitosis. Cell (1995) 81:149-152.
34. HOYT MA: Eliminating all obstacles: regulated proteolysis in the eukaryotic cell cycle. Cell (1997) 91:149-151.
35. KOEPP DM, HARPER JW, ELLEDGE SJ: How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell (1999) 97:431-434.
36. REED SI: G1/S regulatory mechanisms from yeast to man. In: Progress in Cell Cycle Research (Vol 2). Meijer L, Guidet S, Vogel L (Eds.), Plenum Press, New York, NY, USA (1996):15-27.
37. BARTKOVA J, LUKAS J, BARTEK J: Aberrations of the G1-and G1/S-regulating genes in human cancer. In: Progress in Cell Cycle Research (Vol 3). Meijer L, Guidet S, Philippe M (Eds.), Plenum Press, New York, NY, USA (1997):211-220.
38. WEINBERG RA: The retinoblastoma gene and gene product. Cancer Surveys (1992) 12:43-57.
39. RILEY DJ, LEE EYHP, LEE W-H: The retinoblastoma protein: more than a tumor suppressor. Ann. Rev. Cell Biol. (1994) 10:1-29.
40. BARTEK J, BARTKOVA J, LUKAS J: The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. (1996) 8:805-814.
41. TAYA Y: RB kinases and RB-binding proteins: new points of view. Trends Biochem. Sci. (1997) 22:14-17.
42. MITTNACHT S: Control of pRB phosphorylation. Curr. Opin. Genet. Dev. (1998) 8:21-27.
43. KAELIN JR. WG: Functions of the retinoblastoma protein. BioEssays (1999) 21:950-958.
44. GOODRICH DW, PING WANG N, QIAN Y-W, LEE EYHP, LEE W-H: The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell (1991) 67:293-302.
45. BATES S, PARRY D, BONETTA L, VOUSDEN KH, DICKSON C, PETERS G: Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene (1994) 9:1633-1640.
46. LUKAS J, BARTKOVA J, ROHDE M, STRAUSS M, BARTEK J: Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. (1995) 15:2600-2611.
47. OHTSUBO M, THEODORAS AM, SCHUMACHER J, ROBERTS JM, PAGANO M: Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell. Biol. (1995) 15:2612-2624.
48. GENG Y, EATON EN, PICÓN M etal: Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene (1996) 12:1173-1180.
49. TAKEMURA M, KITAGAWA T, IZUTA S etal: Phosphory-lated retinoblastoma protein stimulates DNA polymerase a. Oncogene (1997) 15:2483-2492.
50. KAMB A: Cyclin-dependent kinase inhibitors and human cancer. In: Cyclin Dependent Kinase (CDK) Inhibitors (Vol 227). Vogt PK, Reed SI (Eds.), Springer Verlag, Berlin, Germany (1998):139-148.
51. KIYOKAWA H, KOFF A: Roles of cyclin-dependent kinase inhibitors: lessons from knockout mice. In: Cyclin Dependent Kinase (CDK) Inhibitors (Vol 227). Vogt PK, Reed SI (Eds.), Springer Verlag, Berlin, Germany (1998):105-120.
52. LUKAS J, PARRY D, AAGAARD L et al: Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (1995) 375:503-506.
53. MEDEMA RH, HERRERA RE, LAM F, WEINBERG RA: Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA (1995) 92:6289-6293.
54. GIVOL I, GIVOL D, RULONG S, RESAU J, TSARFATY I, HUGHES SH: Overexpression of human p21waf1/cip1 arrests the growth of chicken embryo fibroblasts transformed by individual oncogenes. Oncogene (1995) 11:2609-2618.
55. SGAMBATO A, ZHANG Y-J, CIAPARRONE M etal: Overex pression of p27Kip1 inhibits the growth of both normal and transformed human mammary epithelial cells. Cancer Res. (1998) 58:3448-3454.
56. SHEIKH MS, ROCHEFORT H, GARCIA M: Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene (1995) 11:1899-1905.
57. WANG X, GOROSPE M, HUANG Y, HOLBROOK NJ: p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene (1997) 15:2991-2997.
58. FRIZELLE SP, GRIM J, ZHOU J et al.: Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression. Oncogene (1998) 16:3087-3095.
59. DI LEONARDO A, LINKE SP, CLARKIN K, WAHL GM: DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. GenesDev. (1994) 8:2540-2551.
60. HANNON GJ, BEACH D: p15INK4Bis a potential effector of TGF-|5-induced cell cycle arrest. Nature (1994) 371:257-261.
61. DATTO MB, LI Y, PANUS JF, HOWE DJ, XIONG Y, WANG X-F: Transforming growth factor P induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA (1995) 92:5545-5549.
62. KAMESAKI H, NISHIZAWA K, MICHAUD GY, COSSMAN J, KIYONO T: TGF-P1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. J. Immunol. (1998) 160:770-777.
63. WOLF BB, GREEN DR: Suicidal tendencies: apoptotic cell death by caspase family proteinases. J. Biol. Chem. (1999) 274:20049-20052.
64. EARNSHAW WC, MARTINS LM, KAUFMANN SH: Mammalian caspases: structure, activation, substrates and functions during apoptosis. Ann. Rev. Biochem. (1999) 68: 383-424.
65. KING KL, CIDLOWSKI JA: Cell cycle regulation and apoptosis. Ann. Rev. Physiol. (1998) 60:601-617.
66. EVAN GI, LITTLEWOOD T: A matter of life and cell death. Science (1998) 281:1317-1322.
67. LUNDBERG AS, WEINBERG RA: Control of the cell cycle and apoptosis. Eur. J. Cancer (1999) 35:531-539.
68. KIRSCHNER MW: Intracellular proteolysis. Trends Biochem. Sci. (1999) 24:M42-M45.
69. SHEAFF RJ, GROUDINE M, GORDON M, ROBERTS JM, CLURMAN BE: Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev (1997) 11:1464-1478.
70. VLACH J, HENNECKE S, AMATI B: Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. EMBOJ. (1997) 16:5334-5344.
71. CAYROL C, DUCOMMUN B: Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21. Oncogene (1998) 17:2437-2444.
72. ZHA J, HARADA H, YANG E, JOCKEL J, KORSMEYER SJ: Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell (1996) 87:619-628.
73. BLUME-JENSEN P, JANKNECHT R, HUNTER T: The Kit receptor promotes cell survival via activation of PI3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136. Curr Biol. (1998) 8:779-782.
74. CARDONE MH, ROY N, STENNICKE HR etal: Regulation of cell death protease caspase-9 by phosphorylation. Science (1998) 282:1318-1321.
75. DOU QP, AN B: RB and apoptotic cell death. Front Biosci. (1998) 3:d419-430.
76. TAN X, WANG JYJ: The caspase-RB connection in cell death. Trends Cell Biol. (1998) 8:116-120.
77. HARBOUR JW, DEAN DC: Rb function in cell-cycle regulation and apoptosis. Nature Cell Biol. (2000) 2:E65-E67.
78. SHERR CJ, ROBERTS JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev (1999) 13:1501-1512.
79. WEINBERG RA: E2F and cell proliferation: a world turned upside down. Cell (1996) 85:457-459.
80. JOHNSON DG: The paradox of E2F1: oncogene and tumor suppressor gene. Mol. Carcinog. (2000) 27:151-157.
81. SEWING A, WISEMAN B, LLOYD AC, LAND H: High-intensity raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell. Biol. (1997) 17:5588-5597.
82. WOODS D, PARRY D, CHERWINSKI H, BOSCH H, LEES E, MCMAHON M: Raf-induced proliferation or cell cycle arrest is determined by the level of raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. (1997) 17:5598-5611.
83. LEVINE AJ: p53, the cellular gatekeeper for growth and division. Cell (1997) 88:323-331.
84. HANAHAN D, WEINBERG RA: The hallmarks of cancer. Cell (2000) 100:57-70.
85. COHEN PTW: Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem. Sci. (1997) 22:245-251.
86. AGGEN JB, NAIRN AC, CHAMBERLIN R: Regulation of protein phosphatase-1. Chem. Biol. (2000) 7:R13-R23.
87. BARFORD D, DAS AK, EGLOFF MP: The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Ann. Rev. Biophys. Biomol. Struct. (1998) 27:133-164.
88. GOLDBERG J, HUANG H-B, KWON Y-G, GREENGARD P, NAIRN AC, KURIYAN J: Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1. Nature (1995) 376:745-753.
89. EGLOFF M-P, COHEN PTW, REINEMER P, BARFORD D: Crystal structure of the catalytic subunit of human protein phosphatase 1 and its complex with tungstate. J. Mol. Biol. (1995) 254:942-959.
90. GRIFFITH JP, KIM JL, KIM EE et al.: X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell (1995) 82:507-522.
91. DAS AK, COHEN PTW, BARFORD D: The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR-mediated protein-protein interactions. EMBOJ. (1998) 17:1192-1199.
92. CHUN Y-S, SHIMA H, NAGASAKI K, SUGIMURA T, NAGAO M: PP172, a testis-specific protein serine/threonine-phosphatase Type 1 catalytic subunit, is associated with a protein having high sequence homology with the 78-kDa glucose-regulated protein, a member of the 70-kDa heat shock protein family. Proc. Natl. Acad. Sci. USA (1994) 91:3319-3323.
93. OLIVIER CJ, SHENOLIKAR S: Physiologic importance of protein phosphatase inhibitors. Front. Biosci. (1998) 3:d961-972.
94. LEE EYC, ZHANG L, ZHAO S et al.: Phosphorylase phosphatase: new horizons for an old enzyme. Front Biosci. (1999) 4:d270-285.
95. SCHÖNTHAL AH: Role of PP2A in intracellular signal transduction pathways. Front. Biosci. (1998) 3:d1262-1273.
96. VIRSHUP DM: Protein phosphatase 2A: a panoply of enzymes. Curr. Opin. Cell Biol. (2000) 12:180-185.
97. ZOLNIEROWICZ S, FAVRE B, HEMMINGS BA: Carboxyl methylation-a new regulatory mechanism for an old enzyme, protein phosphatase 2A. Adv. Prot. Phosphatases (1994) 8:355-369.
98. BERNDT N: Protein dephosphorylation and the intracellular control of the cell number. Front. Biosci. (1999) 4:d22-42.
99. CONNELL-CROWLEY L, ELLEDGE SJ, HARPER JW: G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts. Curr. Biol. (1998) 8:65-68.
100. CORI GT, CORI CF: The enzymatic conversion of phosphorylase a to b. J. Biol. Chem. (1945) 158:321-332.
101. MEIJER L, PONDAVEN P, TUNG HYL, COHEN P, WALLACE RW: Protein phosphorylation and oocyte maturation. II. Inhibition of starfish oocyte maturation by intracellular microinjection of protein phosphatases 1 and 2A and alkaline phosphatase. Exp. Cell Res. (1986) 163:489-499.
102. DOONAN JH, MORRIS NR: The bimGgene of Aspergillus nidulans, required for completion of anaphase, encodes a homolog of mammalian phosphoprotein phosphatase 1. Cell (1989) 57:987-996.
103. OHKURA H, KINOSHITA N, MIYATANI S, TODA T, YANAGIDA M: The fission yeast dis2+gene required for chromosome disjoining encodes one of two putative Type 1 protein phosphatases. Cell (1989) 57:997-1007.
104. BOOHER RN, BEACH D: Involvement of a Type 1 protein phosphatase encoded by bws1+ in fission yeast mitotic control. Cell (1989) 57:1009-1016.
105. AXTON JM, DÓMBRADI V, COHEN PTW, GLOVER DM: One of the protein phosphatase 1 isoenzymes in Drosophila is essential for mitosis. Cell(1990) 63:33-46.
106. FERNANDEZ A, BRAUTIGAN DL, LAMB NJC: Protein phosphatase Type 1 in mammalian cell mitosis: chromosomal localization and involvement in mitotic exit.J. Cell Biol. (1992) 116:1421-1430.
107. TAKAI A, BIALOJAN C, TROSCHKA M, RUEGG JC: Smooth muscle myosin phosphatase inhibition and force enhancement by black sponge toxin. FEBS Lett. (1987) 217:81-84.
108. SUGANUMA M, FUJIKI H, SUGURI H et al.: Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc. Natl. Acad. Sci. USA (1988) 85:1768-1771.
109. COHEN P, COHEN PTW: Protein phosphatases come of age. J. Biol. Chem. (1989) 264:21435-21438.
110. GRUPPUSO PA, MIKUMO R, BRAUTIGAN DL, BRAUN L: Growth arrest induced by transforming growth factor (51 is accompanied by protein phosphatase activation in human keratinocytes. J. Biol. Chem. (1991) 266:3444-3448.
111. LUDLOW JW, GLENDENING CL, LIVINGSTON DM, DECAPRIO JA: Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol. Cell. Biol. (1993) 13:367-372.
112. ALBERTS AS, THORBURN AM, SHENOLIKAR S, MUMBY MC, FERAMISCOJ R: Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. Proc. Natl. Acad. Sci. USA (1993) 90:388-392.
113. DURFEE T, BECHERER K, CHEN P-L etal: The retinoblas toma protein associates with the protein phosphatase Type 1 catalytic subunit. GenesDev. (1993) 7:555-569.
114. BERNDT N: Phosphorylation of protein phosphatase 1 by cyclin-dependent kinases: a novel mechanism for cell cycle control? Adv. Prot. Phosphatases (1995) 9:63-86.
115. DOHADWALA M, DA CRUZ E SILVA EF, HALL FL et al: Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA (1994) 91:6408-6412.
116. BERNDT N, DOHADWALA M, LIU CWY: Constitutively active protein phosphatase 1a causes Rb-dependent G1 arrest in human cancer cells. Curr. Biol. (1997) 7:375-386.
117. LIU CWY, WANG R-H, DOHADWALA M, SCHÖNTHAL AH, VILLA-MORUZZI E, BERNDT N: Inhibitory phosphorylation of PP1a catalytic subunit during the G1/S transition. J. Biol. Chem. (1999) 274:29470-29475.
118. DRISCOLL B, T'ANG A, HU Y-H et al.: Discovery of a regulatory motif which controls the exposure of specific upstream CDK sites that determine both conformation and growth suppressing activity of pRb. J. Biol. Chem. (1999) 274:9463-9471.
119. KRTOLICA A, KRUCHER NA, LUDLOW JW: Hypoxia-induced pRB hypo-phosphorylation results from downregulation of CDK and upregulation of PP1 activities. Oncogene (1998) 17:2295-2304.
120. BRAUTIGAN DL, SUNWOO J, LABBÉ J-C, FERNANDEZ A, LAMB NJC: Cell cycle oscillation of phosphatase inhibitor-2 in rat fibroblasts coincident with p34cdc2 restriction. Nature (1990) 344:74-78.
121. KAKINOKI Y, SOMERS J, BRAUTIGAN DL: Multisite phosphorylation and the nuclear localization of phosphatase inhibitor 2-green fluorescent protein fusion protein during S phase of the cell growth cycle. J. Biol. Chem. (1997) 272:32308-32314.
122. YAMANO H, ISHII K, YANAGIDA M: Phosphorylation of dis2 protein phosphatase at the C-terminal cdc2 consensus and its potential role in cell cycle regula tion. EMBOJ. (1994) 13:5310-5318.
123. SANGRADOR A, ANDRES I, EGUIRAUN A, LORENZO ML, ORTIZ JM: Growth arrest of Schizosaccharomyces pombe following overexpression of mouse Type 1 protein phosphatases. Mol. Gen. Genet. (1998) 259:449-456.
124. KWON Y-G, LEE S-Y, CHOI Y, GREENGARD P, NAIRN AC: Cell cycle-dependent phosphorylation of mammalian protein phosphatase 1 by cdc2 kinase. Proc. Natl. Acad. Sci. USA (1997) 94:2168-2173.
125. PUNTONI F, VILLA-MORUZZI E: Protein phosphatase-1a, y1 and 8: changes in phosphorylation and activity in mitotic HeLa cells and in cells released from the mitotic block. Arch. Biochem. Biophys. (1997) 340:177-184.
126. CHENG AY, DEAN NM, HONKANEN RE: Serine/threonine protein phosphatase Type 1y1 is required for the completion of cytokinesis in human A549 lung carcinoma cells. J. Biol. Chem. (2000) 275:1846-1854.
127. OHKURA H, YANAGIDA M: S. pombe gene sds22+ essential for a midmitotic transition encodes a leucine-rich repeat protein that positively modulates protein phosphatase-1. Cell(1991) 64:149-157.
128. DINISCHIOTU A, BEULLENS M, STALMANS W, BOLLEN M: Identification of sds22 as an inhibitory subunit of protein phosphatase-1 in rat liver nuclei. FEBS Lett. (1997) 402:141-144.
129. NELSON DA, KRUCHER NA, LUDLOW JW: High molecular weight protein phosphatase Type 1 dephos-phorylates the retinoblastoma protein. J. Biol. Chem. (1997) 272:4528-4535.
130. PUNTONI F, VILLA-MORUZZI E: Association of protein phosphatase-18 with the retinoblastoma protein and reversible phosphatase activation in mitotic HeLa cells and in cells released from mitosis. Biochem. Biophys. Res. Commun. (1997) 235:704-708.
131. LORCA T, LABBÉ J-C, DEVAULT A etal: Dephosphorylation of cdc2 on threonine 161 is required for cdc2 kinase inactivation and normal anaphase. EMBO J. (1992) 11:2381-2390.
132. PAULSON JR, PATZLAFF JS, VALLIS AJ: Evidence that the endogenous histone H1 phosphatase in HeLa mitotic chromosomes is protein phosphatase 1, not protein phosphatase 2A.J. Cell Sci. (1996) 109:1437-1447.
133. THOMPSON LJ, BOLLEN M, FIELDS AP: Identification of protein phosphatase 1 as a mitoticlamin phosphatase. J. Biol. Chem. (1997) 272:29693-29697.
134. ISHII K, KUMADA K, TODA T, YANAGIDA M: Requirement for PP1 phosphatase and 20S cyclosome/APC for the onset of anaphase is lessened by the dosage increase of a novel gene sds23+. EMBO J. (1996) 15:6629-6640.
135. FÉLIX M-A, COHEN P, KARSENTI E: Cdc2 H1 kinase is negatively regulated by a Type 2A phosphatase in the Xenopus early embryonic cell cycle: evidence from the effects of okadaic acid. EMBOJ. (1990) 9:675-683.
136. CLARKE PR, HOFFMANN I, DRAETTA G, KARSENTI E: Dephosphorylation of cdc25-C by a Type 2A protein phosphatase: specific regulation during the cell cycle in Xenopuseggextracts. Mol.Biol. Cell(1993) 4:397-411.
137. LEE TH, TURCK C, KIRSCHNER MW: Inhibition of cdc2 activation by INH/PP2A. Mol. Biol. Cell (1994) 5:323-338.
138. KINOSHITA N, OHKURA H, YANAGIDA M: Distinct, essential roles of Type 1 and 2Aprotein phosphatases in the control of the fission yeast cell division cycle. Cell (1990) 63:405-415.
139. KAWABE T, MUSLIN AJ, KORSMEYER SJ: HOX11 interacts with protein phosphatases PP2Aand PP1 and disrupts a G2/M cell-cycle checkpoint. Nature (1997) 385:454-458.
140. VOORHOEVE PM, WATSON RJ, FARLIE PG, BERNARDS R, LAM EWF: Rapid dephosphorylation of p107 following UVirradiation. Oncogene (1999) 18:679-688.
141. LI H, ZHAO L-L, FUNDER JW, LIU J-P: Protein phosphatase 2Ainhibits nuclear telomerase activity in human breast cancer cells. J. Biol. Chem. (1997) 272:16729-16732.
142. GREIDER CW: Telomerase activity, cell proliferation and cancer. Proc. Natl. Acad. Sci. USA (1998) 95:90-92.
143. YAN Y, MUMBY MC: Distinct roles for PP1 and PP2Ain phosphorylation of the retinoblastoma protein.J. Biol Chem. (1999) 274:31917-31924.
144. JARAMILLO-BABB VL, SUGARMAN JL, SCAVETTA R et al: Positive regulation of cdc2 gene activity by protein phosphatase Type 2A. J. Biol. Chem. (1996) 271:5988-5992.
145. LINX H, WALTER J, SCHEIDTMANN K, OHST K, NEWPORT J, WALTER G: Protein phosphatase 2A is required for the initiation of chromosomal DNA replication. Proc Natl. Acad. Sci. USA (1998) 95:14693-14698.
146. PALLAS DC, SHAHRIK LK, MARTIN BL et al: Polyoma small and middle Tantigens and SV40 small Tantigen form stable complexes with protein phosphatase 2A. Cell (1990) 60:167-176.
147. WALTER G, RUEDIGER R, SLAUGHTER C, MUMBY MC: Association of protein phosphatase 2Awith polyoma virus medium tumor antigen. Proc. Natl. Acad. Sci. USA (1990) 87:2521-2525.
148. YANG S-I, LICKTEIG RL, ESTES R, RUNDELL K, WALTER G, MUMBY MC: Control of protein phosphatases 2A by Simian virus 40 small-t antigen. Mol. Cell. Biol. (1991) 11:1988-1995.
149. SONTAG E, FEDOROV S, KAMABAYASHI C, ROBBINS D, COBB MH, MUMBY MC: The interaction of SV40 small tumor antigen with protein phosphatase 2Astimulates the Map kinase pathway and induces cell proliferation. Cell (1993) 75:887-897.
150. CHEN J, MARTIN BL, BRAUTIGAN DL: Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science (1992) 257:1261-1264.
151. CHEN J, PARSONS S, BRAUTIGAN DL: Tyrosine phospho rylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. J. Biol. Chem. (1994) 269:7957-7962.
152. LI M, MAKKINJE A, DAMUNI Z: The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J. Biol. Chem. (1996) 271:11059-11062.
153. AL-MURRANI SWK, WOODGETT JR, DAMUNI Z: Expression of I2PP2A, inhibitor of protein phosphatase 2A, induces c-Jun and AP-1 activity. Biochem. J. (1999) 341:293-298.
154. BAHARIANS Z, SCHÖNTHAL AH: Reduction of Ha-ras-induced cellular transformation by elevated expression of protein phosphatase 2A. Mol. Carcinog. (1999) 24:246-254.
155. YOSHIDA T, TODA T, YANAGIDA M: A calcineurin-like gene ppb1 + in fission yeast: Mutant defects in cytokinesis, cell polarity, mating and spindle pole body positioning.J. Cell Sci. (1994) 107:1725-1735.
156. BAKSH S, DECAPRIO JA, BURAKOFF SJ: Calcineurin regulation of the mammalian G0/G1 checkpoint element, cyclin dependent kinase 4. Oncogene (2000) 19:2820-2827.
157. FISCELLA M, ZHANG HL, FAN SJ et al.: Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc. Natl. Acad. Sci. USA (1997) 94:6048-6053.
158. GUTHRIDGE MA, BELLOSTA P, TAVOLONIN, BASILICO C: FIN13, a novel growth factor-inducible serine-threonine phosphatase which can inhibit cell cycle progression. Mol. Cell. Biol. (1997) 17:5485-5498.
159. ZUO Z, DEAN NM, HONKANEN RE: Serine/threonine protein phosphatase Type 5 acts upstream of p53 to regulate the induction of p21WAF1/Cip1 and mediate growth arrest. J. Biol. Chem. (1998) 273:12250-12258.
160. ZUO Z, URBAN G, SCAMMELL JG et al.: Ser/Thr protein phosphatase Type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. Biochemistry (1999) 38:8849-8857.
161. BASTIANS H, PONSTINGL H: The novel human protein serine/threonine phosphatase 6 is a functional homologue of budding yeast Sit4p and fission yeast ppe1, which are involved in cell cycle regulation.J. Cell Sci. (1996) 109:2865-2874.
162. MARTIN SJ, GREEN DR: Protease activation during apoptosis: death by a thousand cuts? Cell (1995) 82:349-352.
163. KAWAMURA T, MATSUZAWA S, MIZUNO Y et al.: Different moieties of tautomycin involved in protein phosphatase inhibition and induction of apoptosis. Biochem. Pharmacol. (1998) 55:995-1003.
164. BAXTER GD, LAVIN MF: Specific protein dephosphory-lation in apoptosis induced by ionizing radiation and heat shock in human tumor lines. J. Immunol. (1992) 148:1949-1954.
165. DUNIGAN DD, MADLENER JC: Serine/threonine protein phosphatase is required for tobacco mosaic virus-mediated programmed cell death. Virology (1995) 207:460-466.
166. JÄNICKE RU, WALKER PA, LIN XY, PORTER AG: Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J. (1996) 15:6969-6978.
167. CHEN W, OTTERSON GA, LIPKOWITZ S, KHLEIF SN, COXON AB, KAYE FJ: Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene (1997) 14:1243-1248.
168. TAN X, MARTIN SJ, GREEN DR, WANG JYJ: Degradation of retinoblastoma protein in tumor necrosis factor-and CD95-induced cell death. J. Biol. Chem. (1997) 272:9613-9616.
169. BOUTILLIER A-L, TRINH E, LOEFFLER J-P: Caspase-dependent cleavage of the retinoblastoma protein is an early step in neuronal apoptosis. Oncogene (2000) 19:2171-2178.
170. DOU QP, AN B, WILL PL: Induction of a retinoblastoma phosphatase activity by anticancer drugs accompa nies p53-independent G1 arrest and apoptosis. Proc. Natl. Acad. Sci. USA (1995) 92:9019-9023.
171. MORANA SJ, WOLF CM, LI J, REYNOLDS JE, BROWN MK, EASTMAN A: The involvement of protein phosphatases in the activation of ICE/CED-3 protease, intracellular acidification, DNA digestion and apoptosis. J. Biol. Chem. (1996) 271:18263-18271.
172. KNUDSEN KE, WEBER E, ARDEN KC, CAVENEE WK, FERAMISCO JR, KNUDSEN ES: The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death. Oncogene (1999) 18:5239-5245.
173. PUNTONI F, VILLA-MORUZZI E: Protein phosphatase-1 activation and association with the retinoblastoma protein in colcemid-induced apoptosis. Biochem. Biophys. Res. Commun. (1999) 266:279-283.
174. AYLLÓN V, MARTÍNEZ AC, GARCÍA A, CAYLA X, REBOLLO A: Protein phosphatase 1a is a ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis. EMBO J. (2000) 19:2237-2246.
175. MILLS JC, LEE VMY, PITTMAN RN: Activation of a PP2A-like phosphatase and dephosphorylation of tau protein characterize onset of the execution phase of apoptosis.J. Cell Sci. (1998) 111:625-636.
176. DOBROWSKY RT, KAMIBAYASHI C, MUMBY MC, HANNUN YA: Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem. (1993) 268:15523-15530.
177. HANNUN YA: The sphingomeylin cycle and the second messenger function of ceramide. J. Biol. Chem. (1994) 269:3125-3128.
178. ITO T, DENG X, CARR B, MAY WS: Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem. (1997) 272:11671-11673.
179. RUVOLO PP, DENG X, CARR BK, MAY WS: Afunctional role for mitochondrial protein kinase C(X in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem. (1998) 273:25436-25442.
180. DENG XM, ITO T, CARR B, MUMBY MC, MAY WS: Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A. J. Biol. Chem. (1998) 273:34157-34163.
181. RUVOLO PP, DENGX, ITO T, CARB K, MAY WS: Ceramide induces bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J. Biol. Chem. (1999) 274:20292-20300.
182. SANTORO MF, ANNAND RR, ROBERTSON MM et al.: Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. J. Biol. Chem. (1998) 273:13119-13128.
183. SHIBASAKI F, MCKEON F: Calcineurin functions in Ca2+-activated cell death in mammalian cells. J. Cell Biol. (1995) 131:735-743.
184. WANG HG, PATHAN N, ETHELL IM et al.: Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science (1999) 284:339-343.
185. ASAI A, QIU JH, NARITA Y et al.: High level calcineurin activity predisposes neuronal cells to apoptosis. J. Biol Chem. (1999) 274:34450-34458.
186. YOUNG MRI: Protein phosphatases-1 and-2A regulate tumor cell migration, invasion and cytoskeletal organization. Adv. Exp. Med. Biol. (1996) 407:311-318.
187. JACKSON J, MEISINGER J, PATEL S et al.: Protein phosphatase-2A associates with the cytoskeleton to maintain cell spreading and reduced motility of nonmetastatic Lewis lung carcinoma cells: the loss of this regulatory control in metastatic cells. Invasion Metastasis (1998) 17:199-209.
188. BENEFIELD J, MEISINGER J, PETRUZZELLI GJ, YOUNG MRI: Endothelial cell response to human head and neck squamous cell carcinomas involves downregula-tion of protein phosphatases-1/2A, cytoskeletal depolymerization and increased motility. Invasion Metastasis (1998) 17:210-220.
189. ITO A, KATAOKA TR, WATANABE M et al: A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation. EMBO J. (2000) 19:562-571.
190. WEIGMANN K, COHEN SM, LEHNER CF: Cell cycle progression, growth and patterning in imaginal discs despite inhibition of cell division after inactivation of Drosophila Cdc2 kinase. Development (1997) 124:3555-3563.
191. NEUFELD TP, FLOR DE LA CRUZ A, JOHNSTON LA, EDGAR BA: Coordination of growth and cell division in the Drosophilawing. Cell (1998) 93:1183-1193.
192. VERDU J, BURATOVICH MA, WILDER EL, BIRNBAUM MJ: Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nature Cell Biol. (1999) 1:500-506.
193. GOBERDHAN DCI, PARICIO N, GOODMAN EC, MLODZIK M, WILSON C: Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev. (1999) 13:3244-3258.
194. EDGAR BA: From small flies come big discoveries about size control. Nature Cell Biol. (1999) 1:E191-E193.
195. FUJIKI H: Is the inhibition of protein phosphatase 1 and 2A activities a general mechanism of tumor promotion in human cancer development? Mol. Carcinog. (1992) 5:91-94.
196. WANG SS, ESPLIN ED, LI JL et al.: Alterations of the PPP2R1B gene in human lung and colon cancer. Science (1998) 282:284-287.
197. CALIN GA, DIIASIO MG, CAPRINI E et al: Low frequency of alterations of the a (PPP2R1A) and P (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2Ain human neoplasms. Oncogene (2000) 19:1191-1195.
198. TAKAKURA S, KOHNO T, SHIMIZU K, OHWADA S, OKAMOTO A, YOKOTA J: Somatic mutations and genetic polymorphisms of the PPP1R3 gene in patients with several types of cancers. Oncogene (2000) 19:836-840.
199. GOTZ J, PROBST A, EHLER E, HEMMINGS BA, KUES W: Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit C(X. Proc. Natl. Acad. Sci. USA (1998) 95:12370-12375.
200. SOGAWA K, YAMADA T, MASAKI T et al.: Enhanced expression of catalytic subunits of protein phosphatase Type 1 and high S-phase fraction in liposarcoma. Res. Commun. Mol. Pathol. Pharmacol. (1994) 85:359-362.
201. YAMADA T, SOGAWA K, MASAKI T et al.: Enhanced expression of catalytic subunit isoform PP1γ1 of protein phosphatase Type 1 in malignant fibrous histiocytoma. Res. Commun. Mol. Pathol. Pharmacol. (1994) 86:125-128.
202. SOGAWA K, YAMADA T, FUNAMOTO Y et al.: Selective increase in expression of isoform PP1γ1 of type-1 protein phosphatase in chondrosarcoma cells. Res. Commun. Mol. Pathol. Pharmacol. (1994) 86:375-378.
203. SOGAWA K, YAMADA T, OKA S et al.: Enhanced expression of catalytic subunit isoform PP1γ1 of protein phosphatase Type 1 associated with malignancy of osteogenic tumor. Cancer Lett. (1995) 89:1-6.
204. SOGAWA K, MASAKI T, MIYAUCHI A et al.: Enhanced expression of PP1γ1, a catalytic subunit isoform of protein phosphatase Type 1, in invasive ductal carcinomaofthebreast. Cancer Lett. (1997) 112:263-268.
205. PEEPER DS, UPTON TM, LADHA MH et al.: Ras signalling linked to the cell-cycle machinery by the retinoblas-toma protein. Nature (1997) 386:177-180.
206. MITTNACHT S, PATERSON H, OLSON MF, MARSHALL CJ: Ras signalling is required for inactivation of the tumor suppressor pRb cell-cycle control protein. Curr. Biol. (1997) 7:219-221.
207. FOIANI M, LIBERI G, LUCCHINI G, PLEVANI P: Cell cycle-dependent phosphorylation and dephosphorylation of the yeast DNA polymerase α-primaseBsubunit.Mol. Cell. Biol. (1995) 15:883-891.
208. WELLS NJ, FRY AM, GUANO F, NORBURY C, HICKSON ID: Cell cycle phase-specific phosphorylation of human topoisomerase IIα. J. Biol. Chem. (1995) 270:28357-28363.
209. HAGIWARA M, ALBERTS AS, BRINDLE P et al.: Transcrip-tional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB. Cell (1992) 70:105-113.
210. KITAGAWA M, HIGASHI H, SUZUKI-TAKAHASHI I et al.: Phosphorylation of E2F-1 by cyclin A-cdk2. Oncogene (1995) 10:229-236.
211. TRZEPACZ C, LOWY AM, KORDICH JJ, GRODEN J: Phosphorylation of the tumor suppressor adenoma-tous polyposis coli (APC) by the cyclin-dependent kinase p34cdc2. J. Biol. Chem. (1997) 272:21681-21684.
212. KUDOH T, ISHIDATE T, MORIYAMA M, TOYOSHIMA K, AKIYAMA T: G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes. Proc. Natl. Acad. Sci. USA (1995) 92:4517-4521.
213. KIM J,LEE JM, BRANTON PE, PELLETIERJ:Modification of EWS/WT1 functional properties by phosphorylation. Proc. Natl. Acad. Sci. USA (1999) 96:14300-14305.
214. BALDI A, DELUCA A, CLAUDIO PP et al.: The Rb2/p130 gene product is a nuclear protein whose phosphoryla-tion is cell cycle regulated. J. Cell. Biochem. (1995) 59:402-408.
215. CHEN Y, FARMER AA, CHEN C-F, JONES DC, CHEN P-L, LEE W-H: BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. (1996) 56:3168-3172.
216. ANDREASSEN PR, LACROIX FB, VILLA-MORUZZI E, MARGOLIS RL: Differential subcellular localization of protein phosphatase-1 a, y1 and 8 isoforms during both interphase and mitosis in mammalian cells.J. Cell Biol. (1998) 141:1207-1215.
217. HSU L-C, WHITE RL: BRCA1 is associated with the centrosome during mitosis. Proc. Natl. Acad. Sci. USA (1998) 95:12983-12988.
218. APRELIKOVA ON, FANG BS, MEISSNER EG et al: BRCA1-associated growth arrest is RB-dependent. Proc. Natl. Acad. Sci. USA (1999) 96:11866-11871.
219. CHENG AY, BALCZON R, ZUO Z, KOONS JS, WALSH AH, HONKANEN RE: Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles and the inhibition of serine/threonine protein phosphatase activity. Cancer Res. (1998) 58:3611-3619.
220. ARBER N, DOKI Y, HAN EKH et al.: Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res. (1997) 57:1569-1574.
221. SAUTER ER, NESBIT M, LITWIN S, KLEIN-SZANTO AJP, CHEFFETZ S, HERLYN M: Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Res. (1999) 59:4876-4881.